Letronat 2.5 mg Tablet

उत्पाद विवरण

Letronat 2.5 mg Tablet is a potent aromatase inhibitor specifically designed for the treatment of hormone receptor-positive breast cancer in postmenopausal women. By effectively blocking the aromatase enzyme, Letronat reduces estrogen levels in the body, which can slow down or stop the growth of certain types of breast tumors that rely on this hormone. In addition to its primary role in treating active breast cancer, Letronat is also used as a preventive measure to reduce the risk of cancer recurrence. Patients should be aware of potential side effects, including hot flashes, fatigue, and joint pain, and it is essential to inform your healthcare provider of any existing medical conditions or medications before starting treatment. Regular monitoring and follow-up appointments are crucial to ensure the effectiveness and safety of this medication. Letronat 2.5 mg Tablet exemplifies a targeted approach in breast cancer management, making it a vital option for many women facing this diagnosis. Always consult a healthcare professional for personalized advice and comprehensive care during your treatment journey.